En esta página
AURA Aura Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 11, 2026
$6,09
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$4,73mínimo 52 semanas
$9,54máximo 52 semanas
Capitalización Bursátil (MRQ)
$630M
P/E
-3.5
BPA
$-1.76
tus insignias
Rango 52S
$5–$10
Calificación del Analista
BUY
Precio Objetivo
$17
P/E
-3.5
ROE
-68.2%
Margen de Beneficio Neto
-1601.4%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
AURA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$6.09
Capitalización Bursátil (MRQ)
$630M
P/E
-3.5
BPA
$-1.76
ROE
-68.2%
Rango 52S
$5–$10
AURA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-1.762021-12-31 → 2025-12-31
Flujo de caja libre$-85M2021-12-31 → 2025-12-31
Margen neto-1601.4%2021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | AURA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -3.5promedio 5A ≈-3.9 | ≈-3.9 | · | · | |
| P/S | 58.4promedio 5A ≈9615.9 | ≈9615.9 | 367.1 | Infravalorado | |
| P/C (MRQ) | 2.0promedio 5A ≈2.6 | ≈2.6 | 2.6 | Valor razonable | |
| Precio / FCF (TTM) | -6.1promedio 5A ≈-7.7 | ≈-7.7 | · | · | |
| Precio / Flujo de Caja (TTM) | -6.1promedio 5A ≈-8.0 | ≈-8.0 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 2.8promedio 5A ≈2.5 | ≈2.5 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | AURA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | -1701.0%promedio 5A ≈-69277.2% | ≈-69277.2% | -2083.6% | En línea | |
| EBITDA Margin (Margen EBITDA) | -1701.0%promedio 5A ≈-69277.2% | ≈-69277.2% | -2083.6% | En línea | |
| Pretax Margin (Margen antes de impuestos) | -1599.8% | · | -5050.3% | De primer nivel | |
| Net Profit Margin (Margen de Beneficio Neto) | -1601.4%promedio 5A ≈-69209.3% | ≈-69209.3% | -1978.2% | En línea | |
| ROA | -60.4%promedio 5A ≈-42.4% | ≈-42.4% | -38.2% | Débil | |
| ROE | -68.2%promedio 5A ≈-122.6% | ≈-122.6% | -43.9% | Débil | |
| ROIC | -82.5% | · | -36.2% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | AURA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 16.8promedio 5A ≈14.7 | ≈14.7 | 13.8 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 3.2promedio 5A ≈9.4 | ≈9.4 | 6.4 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | AURA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -29.7%promedio 5A ≈3644.8% | ≈3644.8% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 52.7% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | AURA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | 0.0 | De primer nivel |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-6.2%
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 6, 2026 | $-0.48 | $-0.38 | -25.8% |
| 31 de marzo de 2026 | May 7, 2026 | $-0.50 | $-0.41 | -23.3% |
| 31 de diciembre de 2025 | $-0.37 | $-0.44 | 15.2% | |
| 30 de septiembre de 2025 | $-0.40 | $-0.48 | 15.9% | |
| 30 de junio de 2025 | $-0.47 | $-0.47 | -0.71% | |
| 31 de marzo de 2025 | $-0.55 | $-0.50 | -9.8% | |
| 31 de diciembre de 2024 | $-0.52 | $-0.45 | -14.9% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $90M | $73M | $65M | $42M | $25M | $18M | |
| SG&A Expense | $22M | $23M | $20M | $18M | $10M | $4M | |
| Operating Income | $-113M | $-96M | $-85M | $-60M | $-35M | $-22M | |
| Other Non-op | $77.0K | $-120.0K | $-76.0K | $-14.0K | $-1.0K | · | |
| Pretax Income | $-106M | $-87M | $-76M | $-59M | · | · | |
| Income Tax | $108.0K | $112.0K | $137.0K | $0 | $0 | $0 | |
| Net Income | $-106M | $-87M | $-76M | $-59M | $-35M | $-22M | |
| EPS (Basic) | $-1.76 | $-1.75 | $-1.93 | $-1.96 | $-8.95 | · | |
| EPS (Diluted) | $-1.76 | $-1.75 | $-1.93 | $-1.96 | $-8.95 | · | |
| Shares (Basic) | 60,337,608 | 49,650,480 | 39,620,036 | 29,937,228 | 5,159,973 | · | |
| Shares (Diluted) | 60,337,608 | 49,650,480 | 39,620,036 | 29,937,228 | 5,159,973 | · | |
| EBITDA | $-113M | $-96M | · | $-60M | $-35M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $32M | $41M | $122M | $149M | $17M | |
| Prepaid Expense | $5M | $10M | $6M | $8M | $5M | $1M | |
| Other Current Assets | $660.0K | $2M | $2M | $715.0K | $66.0K | $16.0K | |
| Current Assets | $150M | $161M | $232M | $197M | $154M | $18M | |
| PP&E (Net) | $3M | $3M | $3M | $5M | $5M | $4M | |
| PP&E (Gross) | $10M | $9M | $8M | $9M | $8M | $6M | |
| Accum. Depreciation | $7M | $6M | $5M | $4M | $3M | $2M | |
| Other Non-current Assets | $471.0K | $518.0K | $509.0K | $423.0K | · | · | |
| Total Assets | $169M | $183M | $255M | $224M | $160M | $22M | |
| Accounts Payable | $2M | $2M | $2M | $3M | $2M | $611.0K | |
| Current Liabilities | $18M | $15M | $12M | $10M | $7M | $3M | |
| Capital Leases | $14M | $16M | $17M | $18M | $360.0K | · | |
| Total Liabilities | $33M | $31M | $29M | $28M | $8M | $3M | |
| Paid-in Capital | $617M | $526M | $513M | $407M | $304M | $8M | |
| Retained Earnings | $-480M | $-374M | $-287M | $-211M | $-152M | $-117M | |
| Treasury Stock | $0 | · | · | · | · | · | |
| AOCI | $-102.0K | $263.0K | $539.0K | $-72.0K | · | · | |
| Stockholders' Equity | $137M | $152M | $226M | $196M | $152M | $-109M | |
| Liabilities + Equity | $169M | $183M | $255M | $224M | $160M | $22M | |
| Shares Outstanding | 63,587,777 | 49,998,279 | 49,350,788 | 37,771,918 | 29,211,643 | 381,123 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $12M | $9M | $6M | $2M | $736.0K | |
| Operating Cash Flow | $-85M | $-80M | $-64M | $-55M | $-32M | $-24M | |
| CapEx | $447.0K | $1M | $709.0K | $1M | $2M | $771.0K | |
| Investing Cash Flow | $36M | $69M | $-114M | $-68M | $-2M | $-771.0K | |
| Stock Issued | $47M | $0 | · | $87M | $79M | · | |
| Net Stock Activity | $47M | · | · | $87M | $79M | · | |
| Financing Cash Flow | $77M | $2M | $97M | $96M | $166M | $10M | |
| Net Change in Cash | · | $-9M | $-81M | $-27M | $132M | $-15M | |
| Taxes Paid | $100.0K | $100.0K | · | · | · | · | |
| Free Cash Flow | $-85M | $-81M | · | $-56M | $-35M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1701.0% | -1019.4% | · | -3234.7% | -271153.9% | · | |
| Net Margin | -1601.4% | -921.8% | · | -3152.5% | -271161.5% | · | |
| Pretax Margin | -1599.8% | -920.6% | · | · | · | · | |
| EBITDA Margin | -1701.0% | -1019.4% | · | -3234.7% | -271153.9% | · | |
| ROA | -60.4% | -39.7% | · | -30.6% | -38.7% | · | |
| ROE | -68.2% | -53.2% | · | -37.8% | -331.0% | · | |
| ROIC | -82.5% | -63.3% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | 10.8 | · | 18.8 | 21.1 | · | |
| Quick Ratio | 3.2 | 2.1 | · | 11.6 | 20.5 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.15 | $3.04 | · | $5.18 | $5.21 | · | |
| Revenue / Share | $0.11 | $0.19 | · | $0.06 | · | · | |
| Cash Flow / Share | $-1.40 | $-1.61 | · | $-1.82 | · | · | |
| Cash / Share | $0.94 | $0.63 | · | $3.22 | $5.10 | · | |
| EPS (TTM) | $-1.76 | $-1.75 | $-1.93 | $-1.96 | $-8.95 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -29.7% | 9.8% | 360.7% | 14238.5% | · | · | |
| Revenue CAGR 3Y | 52.7% | 798.5% | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $9M | $9M | $2M | $13.0K | · | |
| Net Income TTM | $-106M | $-87M | $-76M | $-59M | $-35M | · | |
| Market Cap | $347M | $411M | · | $397M | $496M | · | |
| P/E | -3.1 | -4.7 | -4.6 | -5.4 | -1.9 | · | |
| P/S | 52.3 | 43.6 | · | 212.8 | 38154.9 | · | |
| P/B | 2.5 | 2.7 | · | 2.0 | 3.3 | · | |
| P / Tangible Book | 2.5 | 2.7 | 1.9 | 2.0 | 3.3 | · | |
| P / Cash Flow | -4.1 | -5.1 | · | -7.3 | -15.3 | · | |
| P / FCF | -4.1 | -5.1 | · | -7.1 | -14.4 | · | |
| Earnings Yield | -32.3% | -21.3% | -21.8% | -18.7% | -52.7% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $31M | $28M | $22M | $22M | $23M | $23M | $22M | $17M | $17M | $17M | $20M | $15M | $15M | $14M | $13M | $11M | |
| SG&A Expense | $17M | $7M | $5M | $6M | $6M | $6M | $5M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $4M | $5M | |
| Operating Income | $-48M | $-35M | $-27M | $-28M | $-29M | $-29M | $-28M | $-23M | $-23M | $-22M | $-25M | $-20M | $-20M | $-19M | $-18M | $-16M | |
| Other Non-op | $154.0K | $2.0K | $150.0K | $-13.0K | $-36.0K | $-24.0K | $-37.0K | $-25.0K | $-26.0K | $-32.0K | $-26.0K | $-5.0K | $-32.0K | $-13.0K | $303.0K | $-329.0K | |
| Pretax Income | $-46M | $-34M | $-26M | $-26M | $-27M | $-27M | $-26M | $-21M | $-20M | $-20M | $-22M | $-19M | $-18M | $-17M | · | · | |
| Income Tax | $29.0K | $11.0K | $16.0K | $26.0K | $48.0K | $18.0K | $24.0K | $43.0K | $0 | $46.0K | $137.0K | $0 | $0 | $0 | · | · | |
| Net Income | $-46M | $-34M | $-26M | $-26M | $-27M | $-27M | $-26M | $-21M | $-20M | $-20M | $-22M | $-19M | $-18M | $-17M | $-17M | $-16M | |
| EPS (Basic) | $-0.48 | $-0.50 | $-0.34 | $-0.40 | $-0.47 | $-0.55 | $-0.52 | $-0.42 | $-0.41 | $-0.40 | $-0.51 | $-0.48 | $-0.48 | $-0.46 | $-0.52 | $-0.54 | |
| EPS (Diluted) | $-0.48 | $-0.50 | $-0.34 | $-0.40 | $-0.47 | $-0.55 | $-0.52 | $-0.42 | $-0.41 | $-0.40 | $-0.51 | $-0.48 | $-0.48 | $-0.46 | $-0.52 | $-0.54 | |
| Shares (Basic) | 94,863,400 | 67,447,576 | · | 65,936,672 | 58,015,718 | 50,126,148 | · | 49,663,532 | 49,548,120 | 49,451,943 | · | 38,185,197 | 37,855,533 | 37,784,282 | · | 29,273,577 | |
| Shares (Diluted) | 94,863,400 | 67,447,576 | · | 65,936,672 | 58,015,718 | 50,126,148 | · | 49,663,532 | 49,548,120 | 49,451,943 | · | 38,185,197 | 37,855,533 | 37,784,282 | · | 29,273,577 | |
| EBITDA | $-48M | $-35M | · | $-28M | $-29M | $-29M | · | $-23M | $-23M | $-22M | · | $-20M | $-20M | $-19M | · | $-16M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $68M | $85M | $60M | $48M | $107M | $38M | $32M | $25M | $30M | $26M | $41M | $56M | $48M | $38M | $122M | $61M | |
| Prepaid Expense | $5M | $4M | $5M | $8M | $7M | $7M | $10M | $9M | $8M | $9M | $6M | $5M | $4M | $6M | $8M | $4M | |
| Other Current Assets | $819.0K | $1M | $1M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $566.0K | $988.0K | $771.0K | $715.0K | $306.0K | |
| Current Assets | $329M | $119M | $150M | $170M | $184M | $135M | $161M | $183M | $196M | $212M | $232M | $154M | $166M | $179M | $197M | $116M | |
| PP&E (Net) | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | |
| PP&E (Gross) | $10M | $10M | $10M | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $10M | $10M | $9M | $9M | $9M | |
| Accum. Depreciation | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | |
| Other Non-current Assets | $1M | $517.0K | $471.0K | $277.0K | $185.0K | $0 | $518.0K | $22.0K | $443.0K | $453.0K | $509.0K | $685.0K | $700.0K | $623.0K | $423.0K | · | |
| Total Assets | $348M | $138M | $169M | $190M | $204M | $155M | $183M | $205M | $218M | $235M | $255M | $180M | $193M | $206M | $224M | $143M | |
| Accounts Payable | $2M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $553.0K | $1M | $3M | $2M | |
| Current Liabilities | $20M | $17M | $18M | $19M | $15M | $12M | $15M | $15M | $11M | $10M | $12M | $11M | $9M | $8M | $10M | $10M | |
| Capital Leases | $13M | $14M | $14M | $15M | $15M | $15M | $16M | $16M | $16M | $17M | $17M | $17M | $17M | $18M | $18M | $18M | |
| Total Liabilities | $33M | $30M | $33M | $33M | $30M | $27M | $31M | $31M | $27M | $26M | $29M | $28M | $26M | $26M | $28M | $28M | |
| Common Stock | $1.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Paid-in Capital | $915M | $622M | $617M | $611M | $603M | $530M | $526M | $522M | $519M | $516M | $513M | $417M | $413M | $409M | $407M | $310M | |
| Retained Earnings | $-560M | $-514M | $-480M | $-455M | $-429M | $-402M | $-374M | $-348M | $-327M | $-307M | $-287M | $-265M | $-247M | $-228M | $-211M | $-194M | |
| Treasury Stock | $39M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $-670.0K | $-207.0K | $-102.0K | $69.0K | $25.0K | $105.0K | $263.0K | $607.0K | $-183.0K | $18.0K | $539.0K | $-134.0K | $-223.0K | $-45.0K | $-72.0K | $-147.0K | |
| Stockholders' Equity | $315M | $107M | $137M | $157M | $175M | $128M | $152M | $175M | $191M | $209M | $226M | $152M | $166M | $180M | $196M | $115M | |
| Liabilities + Equity | $348M | $138M | $169M | $190M | $204M | $155M | $183M | $205M | $218M | $235M | $255M | $180M | $193M | $206M | $224M | $143M | |
| Shares Outstanding | 103,480,053 | 64,150,468 | 63,587,777 | 62,985,569 | 62,071,050 | 50,225,312 | 49,998,279 | 49,778,861 | 49,583,358 | 49,504,405 | 49,350,788 | 38,216,717 | 38,086,606 | 37,800,102 | 37,771,918 | 29,283,285 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $12M | $4M | $3M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-33M | $-30M | $-20M | $-20M | $-21M | $-23M | $-24M | $-15M | $-16M | $-24M | $-17M | $-15M | $-15M | $-16M | $-18M | $-11M | |
| CapEx | $21.0K | $102.0K | $176.0K | $45.0K | $39.0K | $187.0K | $299.0K | $341.0K | $525.0K | $88.0K | $317.0K | $90.0K | $193.0K | $109.0K | $358.0K | $63.0K | |
| Investing Cash Flow | $-226M | $55M | $30M | $-44M | $20M | $30M | $30M | $10M | $20M | $9M | $-90M | $22M | $21M | $-67M | $-17M | $18M | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $242M | $300.0K | $3M | $4M | $70M | $96.0K | $543.0K | $716.0K | $83.0K | $253.0K | $93M | $2M | $2M | $201.0K | $95M | $104.0K | |
| Net Change in Cash | · | · | · | · | · | · | · | $-5M | $4M | $-15M | $-15M | $8M | $9M | $-83M | $60M | $7M | |
| Free Cash Flow | · | $-30M | · | · | · | $-24M | · | · | · | $-25M | · | · | · | $-17M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2083.6% | -2929.9% | · | -1537.5% | -1705.2% | -1821.5% | · | -1028.9% | -928.7% | -831.0% | · | -1034.2% | -1009.3% | -976.6% | · | -3324.0% | |
| Net Margin | -1978.2% | -2830.7% | · | -1439.7% | -1610.2% | -1724.1% | · | -931.9% | -829.7% | -733.9% | · | -934.5% | -910.8% | -877.3% | · | -3292.1% | |
| Pretax Margin | -1976.9% | -2829.8% | · | -1438.2% | -1607.3% | -1723.0% | · | -930.0% | -829.7% | -732.2% | · | · | · | · | · | · | |
| EBITDA Margin | -2083.6% | -2929.9% | · | -1537.5% | -1705.2% | -1821.5% | · | -1028.9% | -928.7% | -831.0% | · | -1034.2% | -1009.3% | -976.6% | · | -3324.0% | |
| ROA | -16.5% | -23.0% | · | -13.2% | -12.8% | -14.1% | · | -10.9% | -9.9% | -8.9% | · | -11.5% | -11.2% | -9.9% | · | -13.6% | |
| ROE | -18.6% | -28.6% | · | -15.8% | -14.8% | -16.3% | · | -12.9% | -11.4% | -10.1% | · | -13.9% | -12.4% | -10.9% | · | 199.2% | |
| ROIC | -15.3% | -32.5% | · | -17.8% | -16.4% | -22.7% | · | -13.3% | · | -10.7% | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.8 | 7.1 | · | 9.0 | 12.4 | 11.1 | · | 12.5 | 18.5 | 22.0 | · | 14.1 | 18.7 | 22.1 | · | 11.6 | |
| Quick Ratio | 3.5 | 5.1 | · | 2.5 | 7.2 | 3.1 | · | 1.7 | 2.9 | 2.7 | · | 5.1 | 5.4 | 4.7 | · | 6.1 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.05 | $1.67 | · | $2.49 | $2.81 | $2.55 | · | $3.51 | $3.86 | $4.22 | · | $3.97 | $4.37 | $4.77 | · | $3.93 | |
| Revenue / Share | $0.02 | $0.02 | · | $0.03 | $0.03 | $0.03 | · | $0.05 | $0.05 | $0.05 | · | $0.05 | $0.05 | $0.05 | · | $0.02 | |
| Cash Flow / Share | · | $-0.44 | · | · | · | $-0.47 | · | · | · | $-0.49 | · | · | · | $-0.43 | · | · | |
| Cash / Share | $0.66 | $1.32 | · | $0.76 | $1.73 | $0.76 | · | $0.51 | $0.61 | $0.53 | · | $1.45 | $1.25 | $1.02 | · | $2.09 | |
| EPS (TTM) | $-1.72 | $-1.71 | · | $-1.94 | $-1.96 | $-1.90 | · | $-1.74 | $-1.80 | $-1.87 | · | $-1.94 | $-2.00 | $-1.98 | · | $67.54 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $6M | · | $7M | $8M | $8M | · | $10M | $10M | $9M | · | $7M | $6M | $4M | · | $805.0K | |
| Net Income TTM | $-131M | $-112M | · | $-106M | $-101M | $-95M | · | $-83M | $-81M | $-79M | · | $-71M | $-68M | $-63M | · | $-54M | |
| Market Cap | $735M | $429M | · | $389M | $389M | $294M | · | $444M | $375M | $389M | · | $343M | $470M | $351M | · | $531M | |
| P/E | -4.1 | -3.9 | · | -3.2 | -3.2 | -3.1 | · | -5.1 | -4.2 | -4.2 | · | -4.6 | -6.2 | -4.7 | · | 0.3 | |
| P/S | 107.2 | 68.9 | · | 54.7 | 51.4 | 35.3 | · | 44.3 | 38.5 | 41.9 | · | 48.7 | 84.8 | 91.6 | · | 659.1 | |
| P/B | 2.3 | 4.0 | · | 2.5 | 2.2 | 2.3 | · | 2.5 | 2.0 | 1.9 | · | 2.3 | 2.8 | 1.9 | · | 4.6 | |
| P / Tangible Book | 2.3 | 4.0 | · | 2.5 | 2.2 | 2.3 | · | 2.5 | 2.0 | 1.9 | · | 2.3 | 2.8 | 1.9 | · | 4.6 | |
| P / Cash Flow | · | -14.4 | · | · | · | -12.6 | · | · | · | -15.9 | · | · | · | -21.4 | · | · | |
| Earnings Yield | -24.2% | -25.6% | · | -31.4% | -31.3% | -32.4% | · | -19.5% | -23.8% | -23.8% | · | -21.6% | -16.2% | -21.3% | · | 372.7% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Margen Operativo % | -1701.0% | -1019.4% | · | -3234.7% | -271153.9% |
| Beneficio neto | $-106M | $-87M | $-76M | $-59M | $-35M |
| EPS Diluido | $-1.76 | $-1.75 | $-1.93 | $-1.96 | $-8.95 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 8.1 | 10.8 | · | 18.8 | 21.1 |
| Ratio Rápido | 3.2 | 2.1 | · | 11.6 | 20.5 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-85M | $-81M | · | $-56M | $-35M |
Propietarios institucionales (13F) 153 declarantes · $721.0M total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
153
Valor en tenencia
$721.0M
Nuevas posiciones
38
Posiciones cerradas
13
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 38 (+11 vs trimestre anterior) | 13 (+1 vs trimestre anterior) | 56 (+20 vs trimestre anterior) | 29 (-11 vs trimestre anterior) | +41.9M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $67 686 664 | 9 533 333 | 9,39% | Acciones |
| MONTANOVA CAPITAL, LLC | $51 164 141 | 7 206 217 | 7,10% | Acciones |
| Frazier Life Sciences Management, L.P. | $50 410 000 | 7 100 000 | 6,99% | Acciones |
| Matrix Capital Management Company, LP | $46 314 000 | 6 922 870 | 6,42% | Acciones |
| Long Focus Capital Management, LLC | $36 349 032 | 5 119 582 | 5,04% | Acciones |
| BlackRock, Inc. | $33 424 486 | 4 707 674 | 4,64% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $32 944 000 | 4 640 000 | 4,57% | Acciones |
| Caligan Partners LP | $30 517 561 | 4 298 248 | 4,23% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $29 112 428 | 4 100 342 | 4,04% | Acciones |
| FCPM III SERVICES B.V. | $28 781 803 | 4 053 775 | 3,99% | Acciones |
| ORBIMED ADVISORS LLC | $23 666 664 | 3 333 333 | 3,28% | Acciones |
| Medicxi Ventures Management (Jersey) Ltd | $21 583 233 | 3 039 892 | 2,99% | Acciones |
| Nantahala Capital Management, LLC | $20 952 313 | 2 951 030 | 2,91% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $17 750 000 | 2 500 000 | 2,46% | Acciones |
| Balyasny Asset Management L.P. | $16 717 795 | 2 354 619 | 2,32% | Acciones |
| VANGUARD GROUP INC | $16 004 132 | 2 936 538 | 2,22% | Acciones |
| FRANKLIN RESOURCES INC | $14 716 355 | 2 072 726 | 2,04% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $12 462 919 | 1 754 721 | 1,73% | Acciones |
| Redmile Group, LLC | $11 833 336 | 1 666 667 | 1,64% | Acciones |
| EcoR1 Capital, LLC | $11 833 336 | 1 666 667 | 1,64% | Acciones |
| Trails Edge Capital Partners, LP | $10 247 665 | 1 443 333 | 1,42% | Acciones |
| Foresite Capital Management VI LLC | $9 466 671 | 1 333 334 | 1,31% | Acciones |
| STATE STREET CORP | $8 683 186 | 1 222 984 | 1,20% | Acciones |
| Woodline Partners LP | $8 592 299 | 1 210 183 | 1,19% | Acciones |
| Bellevue Group AG | $8 283 336 | 1 166 667 | 1,15% | Acciones |
| Vivo Capital, LLC | $8 283 336 | 1 166 667 | 1,15% | Acciones |
| ACORN CAPITAL ADVISORS, LLC | $6 596 447 | 929 077 | 0,91% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $6 435 128 | 906 356 | 0,89% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6 186 528 | 871 342 | 0,86% | Acciones |
| LEVIN CAPITAL STRATEGIES, L.P. | $5 950 276 | 838 067 | 0,83% | Acciones |
| B Group, Inc. | $5 426 125 | 764 243 | 0,75% | Acciones |
| STEMPOINT CAPITAL LP | $5 071 388 | 714 280 | 0,70% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $4 524 148 | 637 204 | 0,63% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $4 392 726 | 618 891 | 0,61% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $4 384 016 | 617 467 | 0,61% | Acciones |
| AWM Investment Company, Inc. | $4 198 123 | 591 285 | 0,58% | Acciones |
| NORTHERN TRUST CORP | $3 901 181 | 549 462 | 0,54% | Acciones |
| Regency Capital Management Inc.\DE | $3 836 804 | 540 395 | 0,53% | Acciones |
| GOLDMAN SACHS GROUP INC | $3 299 143 | 464 668 | 0,46% | Acciones |
| FMR LLC | $1 812 851 | 255 331 | 0,25% | Acciones |
| MORGAN STANLEY | $1 240 313 | 174 692 | 0,17% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 236 820 | 174 200 | 0,17% | Acciones |
| Integral Health Asset Management, LLC | $1 207 000 | 170 000 | 0,17% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 158 408 | 163 156 | 0,16% | Acciones |
| XTX Topco Ltd | $1 064 510 | 149 931 | 0,15% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $938 066 | 132 122 | 0,13% | Acciones |
| Quantinno Capital Management LP | $927 658 | 130 656 | 0,13% | Acciones |
| ADAR1 Capital Management, LLC | $924 079 | 130 152 | 0,13% | Acciones |
| Bank of New York Mellon Corp | $842 009 | 118 593 | 0,12% | Acciones |
| PLATINUM INVESTMENT MANAGEMENT LTD | $794 242 | 111 865 | 0,11% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Matrix Capital Management Company LP, David E. Goel ×5 presentaciones | 11 de mayo de 2026 | 0,00% | Enmienda | · | SEC |
| Medicxi Growth I LP, Medicxi Growth Co-Invest I LP, Medicxi Growth I GP Limited, Medicxi Ventures Management (Jersey) Limited | 10 de noviembre de 2021 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 20 insiders · 14 directivos · 8 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Natalie C. Holles | Chief Executive Officer and President | 19 de mayo de 2026 A | 1 153 962 | 0 | 0 | $0 |
| Pinos Elisabet De Los | President and Chief Executive Officer | 2 de marzo de 2026 A | 575 815 | 0 | 3 | $-380 830 |
| Julie B Feder | Chief Financial Officer | 18 de octubre de 2024 M | 134 276 | 0 | 0 | $0 |
| Susan Abu-Absi | Chief Operating Officer | 1 de septiembre de 2026 A | 134 513 | 0 | 0 | $0 |
| Mark De Rosch | Chief Operating Officer | 19 de enero de 2023 A | 58 635 | 0 | 0 | $0 |
| Erica Kratz | Chief Reg. & Quality Officer | 1 de septiembre de 2026 A | 100 885 | 0 | 0 | $0 |
| Amy Elazzouzi | SVP, Finance & PAO | 1 de septiembre de 2026 A | 143 600 | 0 | 3 | $-56 632 |
| Janet Jill Hopkins | Chief Medical Officer | 1 de septiembre de 2026 A | 380 190 | 0 | 2 | $-195 960 |
| Julie Person | Chief People Officer | 1 de septiembre de 2026 A | 107 611 | 0 | 0 | $0 |
| Conor Kilroy | Chief Legal Officer and Secretary | 1 de julio de 2026 A | 232 693 | 0 | 2 | $-143 400 |
| Anthony S Gibney | Chief Financial and Business Officer. | 16 de junio de 2026 S | 265 354 | 0 | 1 | $-82 330 |
| Mark Plavsic | Chief Technology Officer | 2 de marzo de 2026 A | 243 736 | 0 | 2 | $-157 517 |
| Cadmus Rich | Chief Medical Officer, Head of R&D | 19 de enero de 2023 A | 58 703 | 0 | 0 | $0 |
| Christopher Brett Primiano | Chief Business Officer | 28 de octubre de 2021 A | 8 750 | 0 | 0 | $0 |
| Jeremy Bender | Consejero | 7 de julio de 2026 A | 30 000 | 0 | 0 | $0 |
| Teresa Marie Bitetti | Consejero | 11 de junio de 2026 A | 36 000 | 0 | 0 | $0 |
| David Michael Johnson | Consejero | 11 de junio de 2026 A | 194 167 | 0 | 0 | $0 |
| Antony C. Mattessich | Consejero | 11 de junio de 2026 A | 38 500 | 0 | 0 | $0 |
| Sapna Srivastava | Consejero | 11 de junio de 2026 A | 38 500 | 0 | 0 | $0 |
| Rajesh R Parekh | Consejero | 7 de junio de 2023 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 34 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,73% | 48 490 NS | 31 de julio de 2026 | N-PORT |
| EIS · iShares, Inc. | 0,22% | 340 652 SH | 11 de septiembre de 2026 | Diario |
| VNQI · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,09% | 544 349 SH | 19 de agosto de 2026 | Diario |
| IWC · iShares Trust | 0,07% | 151 855 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 7 337 SH | 2 de octubre de 2026 | Diario |
| IBB · iShares Trust | 0,03% | 500 783 SH | 11 de septiembre de 2026 | Diario |
| SCZ · iShares Trust | 0,03% | 558 487 SH | 11 de septiembre de 2026 | Diario |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 568 052 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 44 692 SH | 19 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,02% | 394 396 SH | 11 de septiembre de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 1 149 779 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 21 415 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1 107 800 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 257 523 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 280 365 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 10 684 SH | 11 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,01% | 174 907 NS | 31 de julio de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 30 891 SH | 2 de octubre de 2026 | Diario |
| DXUV · Dimensional ETF Trust | 0,00% | 3 128 NS | 31 de julio de 2026 | N-PORT |
| IEFA · iShares Trust | 0,00% | 531 838 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 182 735 SH | 11 de septiembre de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,00% | 3 190 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 8 911 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 8 950 SH | 3 de septiembre de 2026 | Diario |
| DFUS · Dimensional ETF Trust | 0,00% | 5 875 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 902 292 SH | 19 de agosto de 2026 | Diario |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 2 197 085 SH | 19 de agosto de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 117 433 SH | 19 de agosto de 2026 | Diario |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 1 463 808 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 555 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 743 SH | 19 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 2 107 NS | 31 de julio de 2026 | N-PORT |
| VSGX · VANGUARD WORLD FUND | 0,00% | 33 754 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 39 492 SH | 11 de septiembre de 2026 | Diario |
AURA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 12 analistas
COMPRA
Objetivo mediano
$15.00
+146,3%
3 25,0%
Compra fuerte
8 66,7%
Compra
1 8,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
5 analistas · 2026-09-28Objetivo medio $16.60 +172,6%
← Por Debajo de Todos los Objetivos
Precio Actual $6.09
Mín$12.00
Media$16.60
Máx$23.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| CLYM | $191M | -4.5 | · | · | -34.6% | · |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| SGMT | · | -3.7 | · | · | -42.3% | · |
| CTMX | $725M | · | -44.8% | -22.8% | -15.9% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 11, 2026